Format

Send to

Choose Destination
PLoS Pathog. 2019 Jun 10;15(6):e1007671. doi: 10.1371/journal.ppat.1007671. eCollection 2019 Jun.

Fimbriae reprogram host gene expression - Divergent effects of P and type 1 fimbriae.

Author information

1
Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Klinikgatan, Lund, Sweden.
2
Institute of Hygiene, University of Münster, Mendelstr, Münster, Germany.
3
Institute for Molecular Biology of Infectious Diseases, University of Würzburg, Würzburg, Germany.
4
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri, United States of America.
5
Center for Women's Infectious Disease Research (CWIDR), Washington University School of Medicine, St Louis, Missouri, United States of America.

Abstract

Pathogens rely on a complex virulence gene repertoire to successfully attack their hosts. We were therefore surprised to find that a single fimbrial gene reconstitution can return the virulence-attenuated commensal strain Escherichia coli 83972 to virulence, defined by a disease phenotype in human hosts. E. coli 83972pap stably reprogrammed host gene expression, by activating an acute pyelonephritis-associated, IRF7-dependent gene network. The PapG protein was internalized by human kidney cells and served as a transcriptional agonist of IRF-7, IFN-β and MYC, suggesting direct involvement of the fimbrial adhesin in this process. IRF-7 was further identified as a potent upstream regulator (-log (p-value) = 61), consistent with the effects in inoculated patients. In contrast, E. coli 83972fim transiently attenuated overall gene expression in human hosts, enhancing the effects of E. coli 83972. The inhibition of RNA processing and ribosomal assembly indicated a homeostatic rather than a pathogenic end-point. In parallel, the expression of specific ion channels and neuropeptide gene networks was transiently enhanced, in a FimH-dependent manner. The studies were performed to establish protective asymptomatic bacteriuria in human hosts and the reconstituted E. coli 83972 variants were developed to improve bacterial fitness for the human urinary tract. Unexpectedly, P fimbriae were able to drive a disease response, suggesting that like oncogene addiction in cancer, pathogens may be addicted to single super-virulence factors.

Conflict of interest statement

A patent regarding therapeutic use of IRF-7 antagonists has been filed. The scientists are shareholders in SelectImmune Pharma AB, a biotech company that holds patents relevant for UTI therapy. This study has not received financial support from SelectImmune Pharma AB or other commercial sources. The authors have declared that no competing interests exist.

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center